Biotech · Private company
Aminex Therapeutics, Inc.
Track this companyFree. Adds Aminex Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- AMXT 1501 DicapratePhase 2 · Melanoma (Skin Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
- AMXT1501Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- CapivasertibPhase 2 · Melanoma (Skin Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
- DFMOPhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- DFMOPhase 2 · Melanoma (Skin Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · Melanoma (Skin Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Melanoma (Skin Cancer)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasPHASE1_PHASE2 · RECRUITING · started May 13, 2026ClinicalTrials.gov NCT06465199 · fetched Nov 12, 2026
- Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Jan 26, 2026ClinicalTrials.gov NCT07287917 · fetched Nov 12, 2026
- Oral AMXT 1501 Dicaprate in Combination With IV DFMOPHASE1_PHASE2 · TERMINATED · started Nov 29, 2022ClinicalTrials.gov NCT05500508 · fetched Nov 12, 2026
- Oral AMXT 1501 Dicaprate in Combination With DFMOPHASE1 · COMPLETED · started Jun 12, 2018ClinicalTrials.gov NCT03536728 · fetched Nov 12, 2026